Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Genpharmasec Limited

Market Cap 432M 4.58M 3.99M 3.7M 3.46M 6.49M 6.53M 43.85M 16.99M 213M 17.18M 16.81M 738M P/E 2024
-545x
P/E 2025 94.5x
Enterprise Value 422M 4.48M 3.9M 3.62M 3.38M 6.35M 6.39M 42.89M 16.62M 208M 16.81M 16.45M 722M EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
55.34%
Yield 2024 *
-
Yield 2025 -
1 day+0.88%
Current month-4.20%
1 month-1.72%
3 months+23.91%
6 months-12.98%
Current year-12.98%
1 week 1.11
Extreme 1.11
1.19
1 month 1.09
Extreme 1.09
1.34
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.2
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
12.4
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 38 31/10/2022
Compliance Officer - 26/03/2024
Director TitleAgeSince
Director/Board Member 57 01/01/2019
Director/Board Member 58 01/01/2019
Director/Board Member - 31/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%0.00%-44.39%-69.35% 6.64M
-0.10%+0.26%-33.23%-16.75% 154B
+1.54%-1.07%-7.45%-11.00% 102B
-4.45%+3.12%+59.84%+56.09% 59.25B
-1.90%-3.49%-8.40%+48.53% 52.89B
+1.67%-1.55%-14.60%-44.33% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-10.54%-44.30% 27.96B
+1.35%-0.26%+50.47%-9.42% 23.17B
-1.53%+1.14%-15.03%-5.42% 20.7B
Average -0.21%-0.59%-2.59%-10.66% 50.99B
Weighted average by Cap. -0.29%-0.33%-5.82%-2.37%

Financials

2024 2025
Net sales 304M 3.22M 2.81M 2.6M 2.44M 4.57M 4.6M 30.87M 11.96M 150M 12.1M 11.84M 520M 337M 3.57M 3.12M 2.89M 2.7M 5.07M 5.1M 34.24M 13.27M 166M 13.42M 13.13M 576M
Net income -1.26M -13.32K -11.62K -10.76K -10.07K -18.89K -19K -128K -49.46K -619K -50.01K -48.93K -2.15M 12.31M 130K 114K 105K 98.64K 185K 186K 1.25M 484K 6.06M 490K 479K 21.04M
Net Debt -179M -1.9M -1.65M -1.53M -1.43M -2.69M -2.7M -18.16M -7.04M -88.04M -7.12M -6.96M -306M -9.4M -99.65K -86.89K -80.47K -75.33K -141K -142K -955K -370K -4.63M -374K -366K -16.07M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
19/06/26 1.140 +0.88% 204,667
18/06/26 1.130 0.00% 192,801
17/06/26 1.130 0.00% 191,079
16/06/26 1.130 -0.88% 90,708
15/06/26 1.140 0.00% 267,063
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!